FRM
HAE icon

Fox Run Management’s Haemonetics HAE Stock Holding History

Fox Run Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,151
Closed -$1.37M – 1032
2025
Q4 		$1.37M Sell
17,151
-10,710
-38% -$720K 0.21% 101
2025
Q3 		$1.36M Buy
+27,861
New +$1.72M 0.21% 118
2025
Q2 		– Sell
-11,191
Closed -$711K – 1007
2025
Q1 		$711K Buy
+11,191
New +$761K 0.11% 324
2023
Q3 		– Sell
-14,030
Closed -$1.19M – 812
2023
Q2 		$1.19M Buy
+14,030
New +$1.19M 0.34% 39
2023
Q1 		– Sell
-12,582
Closed -$990K – 772
2022
Q4 		$990K Buy
+12,582
New +$1.01M 0.4% 20
2021
Q2 		– Sell
-1,889
Closed -$210K – 383
2021
Q1 		$210K Buy
+1,889
New +$234K 0.38% 166
2020
Q1 		– Sell
-6,441
Closed -$740K – 223
2019
Q4 		$740K Buy
+6,441
New +$779K 0.6% 7
2018
Q3 		– Sell
-4,573
Closed -$410K – 672
2018
Q2 		$410K Buy
4,573
+1,431
+46% +$121K 0.13% 320
2018
Q1 		$230K Buy
+3,142
New +$216K 0.06% 585
2017
Q3 		– Sell
-9,700
Closed -$383K – 745
2017
Q2 		$383K Buy
+9,700
New +$398K 0.13% 324
2016
Q3 		– Sell
-8,200
Closed -$238K – 563
2016
Q2 		$238K Buy
8,200
+300
+4% +$9.07K 0.12% 375
2016
Q1 		$276K Buy
+7,900
New +$255K 0.18% 251

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fox Run Management's HAE Position: Q1 2026 in Review

Fox Run Management sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 17,151 shares — an estimated $1.37M sold.

Fox Run Management first reported a position in HAE in Q1 2016 and held it in 12 quarters. The position peaked at $1.37M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Fox Run Management reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
  • Fox Run Management sold 17,151 Haemonetics shares in Q1 2026, an estimated $1.37M.
  • Fox Run Management first reported a position in Haemonetics in Q1 2016 and held it in 12 quarters.
  • Fox Run Management's Haemonetics position peaked at $1.37M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.